| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/13/2007 | WO2007102410A1 Novel use of rage polypeptide |
| 09/13/2007 | WO2007102392A1 Mmp-13-selective inhibitor |
| 09/13/2007 | WO2007102365A1 Anti-viral peptide and use thereof |
| 09/13/2007 | WO2007102326A1 Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 09/13/2007 | WO2007102243A1 External pharmaceutical composition |
| 09/13/2007 | WO2007102242A1 External pharmaceutical composition |
| 09/13/2007 | WO2007102241A1 External pharmaceutical composition |
| 09/13/2007 | WO2007101884A1 Novel use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses |
| 09/13/2007 | WO2007101573A1 Substituted arylsulfonamides as antiviral agents |
| 09/13/2007 | WO2007101560A1 Medicament formulations comprising fluoroquinolones |
| 09/13/2007 | WO2007101441A1 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| 09/13/2007 | WO2007101371A1 Preparation and use of purine bis-amino acid esters |
| 09/13/2007 | WO2007101370A1 Use of glycoconjugate chb in preparing a medicament for preventing or treating flu or poultry influenza |
| 09/13/2007 | WO2007101365A1 New flavane compound and its uses |
| 09/13/2007 | WO2007101337A1 Methods and compositions comprising bacterial type hi secreted proteins for mucosal immunization of animals |
| 09/13/2007 | WO2007073705A3 Pharmaceutical compositions containing protein nma0939 |
| 09/13/2007 | WO2007071692A3 Immunogenic composition |
| 09/13/2007 | WO2007065007A9 Treatment of viral infections |
| 09/13/2007 | WO2007022511A3 Listeria-induced immunorecruitment and activation, and methods of use thereof |
| 09/13/2007 | WO2006130628A3 Combination of hcv protease inhibitors with a surfactant |
| 09/13/2007 | WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/13/2007 | US20070213362 2-nh-heteroarylimidazoles with antibacterial activity |
| 09/13/2007 | US20070213353 Esters in position 20 of camptothecins |
| 09/13/2007 | US20070213320 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
| 09/13/2007 | US20070213291 Therapeutically useful synthetic oligonucleotides |
| 09/13/2007 | US20070213271 Composition and method for treating hiv infection |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212432 Herbal Composition |
| 09/13/2007 | US20070212344 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 09/13/2007 | US20070212302 Preparation and Use of a Stable Formulation of Allosteric Effector Compounds |
| 09/13/2007 | DE102006010720A1 Topisches Produkt zur Stimulation des Wachstums von Propionibakterien und seine Verwendung A topical product for stimulating the growth of Propionibacterium acnes, and its use |
| 09/13/2007 | DE102006010643A1 Using quaternary ammonium compounds to inhibit precipitation of fluoroquinolone antibiotics, particularly in ready-for-use formulations for veterinary medicine |
| 09/13/2007 | CA2645134A1 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6 |
| 09/13/2007 | CA2645110A1 Pharmaceutical composition for external use |
| 09/13/2007 | CA2645072A1 Substituted aminothiazole derivatives with anti-hcv activity |
| 09/13/2007 | CA2645070A1 Pharmaceutical composition for external use |
| 09/13/2007 | CA2645058A1 Pharmaceutical composition for external use |
| 09/13/2007 | CA2644981A1 Pharmaceutical formulation comprising fluoroquinolones |
| 09/13/2007 | CA2642602A1 Substituted arylsulfonamides as antiviral agents |
| 09/13/2007 | CA2638833A1 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| 09/13/2007 | CA2638760A1 Compositions that include hemagglutinin, methods of making and methods of use thereof |
| 09/12/2007 | EP1832662A2 DNA encoding chondroitin synthase from Pasteurella multocida and methods of use |
| 09/12/2007 | EP1832603A2 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy |
| 09/12/2007 | EP1832602A1 Peptides which mimic the antigenic regions of the hepatitis a virus |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832591A1 12-position substituted mutilin derivative |
| 09/12/2007 | EP1832589A1 Inhibitors of cyclin-dependent kinases,compositions and uses related thereto |
| 09/12/2007 | EP1832588A1 Condensed imidazole compound and use thereof |
| 09/12/2007 | EP1832295A1 Use of PTX3 for the treatment of viral diseases |
| 09/12/2007 | EP1831245A1 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 09/12/2007 | EP1831235A2 Lung-targeted drugs |
| 09/12/2007 | EP1831230A1 Process for obtaining levofloxacin free from salts |
| 09/12/2007 | EP1831221A2 Substituted chiral fused 1,2 imidazo 4,5-c ring compounds |
| 09/12/2007 | EP1831210A1 8-aza-bicyclo[3.2.1]octane derivatives with an activity on chemokine ccr5 receptors |
| 09/12/2007 | EP1831174A1 Amide derivatives |
| 09/12/2007 | EP1831164A1 Heterocyclic compounds as ccr2b antagonists |
| 09/12/2007 | EP1830867A2 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv |
| 09/12/2007 | EP1830861A2 Antiviral and immunostimulating marine fish oil composition |
| 09/12/2007 | EP1830858A2 3, 6-bicyclolides |
| 09/12/2007 | EP1830850A1 Quinoline derivatives for the treatment of latent tuberculosis |
| 09/12/2007 | EP1830828A2 Use of methyl pyruvate to increase cellular energy production downstream of glycolysis |
| 09/12/2007 | EP1664059B1 Thienopyrroles as antiviral agents |
| 09/12/2007 | EP1648894B1 Method for the production of oh protected [4-(2.6-diamino-9h-purine-9-yl)- 1.3-dioxolane-2-yl]methanol derivatives |
| 09/12/2007 | EP1558580B1 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 09/12/2007 | EP1558579B1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 09/12/2007 | EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/12/2007 | EP1490382A4 Process of preparing azithromycin and crystalline 9-deoxo-9a-aza-9a-homoerythromycin a hydrate used therein |
| 09/12/2007 | EP1481053B1 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/12/2007 | EP1453830B1 Pyrazolo-pyridine derivatives as antiherpes agents |
| 09/12/2007 | EP1406616B1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1307564B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | EP1299541B1 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/12/2007 | EP1212366B1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 09/12/2007 | EP0651807B1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 09/12/2007 | CN101035785A Novel compounds having an anti-bacterial activity |
| 09/12/2007 | CN101035777A Modulators of hcv replication |
| 09/12/2007 | CN101035773A HIV inhibiting 1.2.4-triazin-6-one derivates |
| 09/12/2007 | CN101035558A Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 09/12/2007 | CN101035555A Combination anti-viral compositions comprising castanospermine and methods of use |
| 09/12/2007 | CN101035536A Combination of organic compounds |
| 09/12/2007 | CN101035529A Novel uses |
| 09/12/2007 | CN101035528A Carbazole and cyclopentaindole derivatives to treat infection with hepatitis C virus |
| 09/12/2007 | CN101033477A Fly maggot oil capable of resisting AIDS, preparing method and use for fatty acid thereof |
| 09/12/2007 | CN101033242A Antenna system for a level measurement apparatus |
| 09/12/2007 | CN101033238A Preparation method and use for purine compounds double amino acid ester |
| 09/12/2007 | CN101033233A Faropenem sodium crystallization and preparation method thereof |
| 09/12/2007 | CN101033224A Novel pyrimidines small molecular compound, its preparation method and use |
| 09/12/2007 | CN101033219A Macrolides compound of Macrolactin Q with antibacterial activity |
| 09/12/2007 | CN101032621A Preparing method of infectious gastroenteritis virus monoclonal antibody immunity biological agent of pigs |
| 09/12/2007 | CN101032607A Medicine for treating pointed condyloma |
| 09/12/2007 | CN101032596A Medicine for treating respiratory tract diseases for chickens and its preparing process |
| 09/12/2007 | CN101032558A Antimicrobial and antipyretic Chinese medicine composition |
| 09/12/2007 | CN101032547A Anti-inflammatory and antivirotic medicine composition |
| 09/12/2007 | CN101032538A Method of preparing substances extracted from Gynura procumbens (Lour.) Merr. and the application |
| 09/12/2007 | CN101032522A Medicine for curing herpes zoster |
| 09/12/2007 | CN101032517A Medicine for curing dermatophytosis |
| 09/12/2007 | CN101032507A Bacteria resisting medicine of erythrocin nanometer-emulsion and the preparing method |
| 09/12/2007 | CN101032498A Physical bacteria resisting net liquid of human body and the producing technique |